- August 12, 2019
Harvard, Merck to collaborate on research led by Harvard immunologist Arlene Sharpe, seeking to identify new pathways for the treatment of cancer
- March 20, 2018
Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development
- September 15, 2016
Scientists at Harvard Medical School discover molecular handle behind some cancers’ preference for fat
- September 28, 2015
A molecule isolated from sea sponges and synthesized at Harvard can halt the growth of cancerous cells.